Vitamin C Affects the Expression of Hepcidin and Erythropoietin Receptor in HepG2 Cells

Journal of Renal Nutrition

Volumn 22, Issue 3, 2012, Pages 373-376

  Chiu, Ping Fang ^a,b   Ko, Shun Yao ^c   Chang, Chia Chu ^b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; ASCORBIC ACID; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HEPCIDIN; MESSENGER RNA;

ARTICLE; CELL STRAIN HEPG2; DOWN REGULATION; DRUG EFFECT; GENETICS; HUMAN; LIVER CELL; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIMICROBIAL CATIONIC PEPTIDES; ASCORBIC ACID; DOWN-REGULATION; ERYTHROPOIETIN; HEP G2 CELLS; HEPATOCYTES; HUMANS; RECEPTORS, ERYTHROPOIETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84860121634     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2011.09.007     Document Type: Article

References (17)

1. Frazer D.M., Anderson G.J. Intestinal iron absorption and its regulation. Am J Physiol Gastrointest Liver Physiol 2005, 289:631-635.
2. Himmelfarb J. Iron regulation. J Am Soc Nephrol 2007, 18:379-381.
3. Graham R.M., Chua A.C., Herbison C.E., et al. Liver iron transport. World J Gastroenterol 2007, 13:4725-4736.
4. Malyszko J., Mysliwiec M. Hepcidin in anemia and inflammation in chronic kidney disease. Kidney Blood Press Res 2007, 30:15-30.
5. Shike H., Lauth X., Westerman M.E., et al. Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur J Biochem 2002, 269:2232-2237.
6. Ganz T. Molecular control of iron transport. J Am Soc Nephrol 2007, 18:394-400.
7. Pinto J.P., Ribeiro S., Pontes H.S., et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPO-R signaling and regulation of C/EBPα. Blood 2008, 111:5727-5733.
8. Kijima H., Sawada T., Tomosugi N., et al. Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma. BMJ Cancer 2008, 8:167-174.
9. Yokomizo R., Matsuzaki S., Uehara S., et al. Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod 2002, 8:441-446.
10. Ashby D.R., Gale D.P., Busbridge M., et al. Plasma hepcidin levels are elevated but responsive to erythropoietin. Kidney Int 2009, 75:976-981.
11. Weiss G., Theurl I., Eder S., et al. Serum hepcidin concentration in chronic hemodialysis patients: associations and effects of dialysis, iron and erythropoietin. Eur J of Clin Invest 2009, 39:883-890.
12. Macdougall I.C. Anaemia of chronic kidney disease. Medicine 2007, 35:457-460.
13. Attallah N., Osman-Malik Y., Frinak S., et al. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Am J Kidney Dis 2006, 47:644-654.
14. Tarng D.C. Novel aspects of vitamin C in epoetin response. J Chin Med Assoc 2007, 70:357-360.
15. Biesalski H.K. Parenteral ascorbic acid in haemodialysis patients. Curr Opin Clin Nutr Metabolic Care 2008, 11:741-746.
16. Tarng D.C., Huang T.P. A parallel comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in hemodialysis patients with iron overload. Nephrol Dial Transplant 1998, 13:2867-2872.
17. Richer A., Kuhlmann M.K., Seibert E., et al. Vitamin C deficiency and secondary hyperparathyroidism in chronic hemodialysis patients. Nephrol Dial Transplant 2008, 23:2058-2063.